Schedule 13G ownership disclosure

Gemphire Therapeutics Inc.

Security class unavailable · CUSIP: 36870A108

Event date: 2017-02-12

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
8.7000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001144204-17-007230
Form type
SC 13G
Filer
Exchange Capital Management, Inc.
CIK
CIK 1317733
Filed
Feb 10, 2017
Reporting period
Feb 12, 2017
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub